Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
Link opens in a new tab
Search content at University of Haifa
Home
Researchers
Research units
Research output
Susceptibility of helicobacter pylori to levofloxacin and rifampicin in Israel
Avi Peretz
, Maya Paritsky
, Eleonora Dinisman-Zavulunov
, Nina Pastukh
, Tatyana Glyatman
, Avi On
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Susceptibility of helicobacter pylori to levofloxacin and rifampicin in Israel'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alternative Antibiotics
20%
Antibiotic Agents
20%
Antrum
20%
Assure
20%
Biopsy Specimen
20%
Helicobacter Pylori (H. pylori)
100%
Israel
100%
Israeli
20%
Levofloxacin
100%
Microbial Resistance
20%
Microbiology Laboratory
20%
Pediatric
20%
Prudent Antimicrobial Use
20%
Prudent Use
20%
Resistance Level
20%
Resistance Rate
20%
Resistant Strains
20%
Rifampicin
100%
Stomach
20%
Strain Identification
20%
Susceptibility Testing
20%
Medicine and Dentistry
Antibiotics
20%
Antiinfective Agent
20%
Antimicrobial Agent
20%
Biopsy Sample
20%
Helicobacter Pylori
100%
Levofloxacin
100%
Pediatrics
20%
Rifampicin
100%
Stomach Biopsy
20%
Immunology and Microbiology
Antimicrobial Agent
33%
Antimicrobial Resistance
33%
Etest
33%
Helicobacter Pylori
100%
Microbiology
33%
Stomach Antrum
33%